Browse articles from EyeWorld.org related to myopia. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.

EyeWorld Weekly, October 29, 2021

➤ FDA approves suprachoroidal injection for macular edema associated with uveitis ➤ FDA approves first-of-its-kind approach to treat wet AMD ➤ Digital therapeutic for pediatric amblyopia receives FDA premarket approval ➤ Ocular insert for dry eye does not meet Phase 2 primary endpoint ➤ Study: Prozac as a possible treatment for AMD ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, October 29, 2021

Stemming myopia progression

Myopia has been described as an epidemic in many regions for some time. Though considered easily correctable with glasses, myopia and high myopia are associated with a risk of developing cataracts sooner and a higher risk for glaucoma and retinal issues.

Comments Off on Stemming myopia progression

EyeWorld Weekly, July 2, 2021

➤ FDA approves drops for vernal keratoconjunctivitis ➤ Data from investigational first-in-class dry eye therapy ➤ FDA accepts BLA for Port Delivery System of ranibizumab ➤ Companies enter collaboration to investigate treatments for dry AMD ➤ ASCRS news and events

Comments Off on EyeWorld Weekly, July 2, 2021

Phakic IOLs: Not perfect, but viable options

The correction of high myopia is limited, but phakic IOLs do provide a surgical option. "For many years we have been looking for a quality anterior chamber phakic IOL that could be easily performed in a clean room rather than an operating room," said Eric D. Donnenfeld, MD, partner at Ophthalmic Consultants of Long Island, Rockville Centre, N.Y., and clinical professor of ophthalmology, New York University Medical School.

Comments Off on Phakic IOLs: Not perfect, but viable options